Zomelis Met (Metformin + Vildagliptin) | Eucreas | Effective Type 2 Diabetes Control
Zomelis Met combines Metformin and Vildagliptin to effectively manage type 2 diabetes. It improves insulin action, reduces glucose production, and supports balanced blood sugar levels with a low risk of hypoglycemia.
Introduction
Zomelis Met is a combination oral antidiabetic medication containing Metformin, a biguanide, and Vildagliptin, a DPP-4 inhibitor. It is designed for adults with type 2 diabetes mellitus to help improve blood sugar control, especially when lifestyle changes and single-drug therapy are insufficient.
This dual-action formula enhances insulin secretion, reduces glucagon levels, and improves insulin sensitivity, making it highly effective for long-term glycemic control.
Precautions of Zomelis Met
- Not for use in type 1 diabetes or diabetic ketoacidosis
- Avoid use in patients with severe kidney or liver impairment
- Use cautiously in individuals over 65 years or with heart failure
- Avoid alcohol due to increased risk of lactic acidosis
- Not recommended during pregnancy or breastfeeding without medical guidance
- Monitor blood sugar, renal function, and liver enzymes regularly
Uses of Zomelis Met
Zomelis Met is used to:
- Manage type 2 diabetes mellitus in adults
- Control fasting and postprandial blood sugar levels
- Reduce the risk of diabetes-related complications
- Provide glycemic control in patients who do not respond adequately to Metformin or Vildagliptin alone
Side Effects of Zomelis Met
Common side effects:
- Nausea or vomiting
- Diarrhea
- Headache
- Dizziness
- Metallic taste
Less common but serious side effects:
- Hypoglycemia, especially when combined with other diabetes medications
- Lactic acidosis (a rare but serious risk associated with Metformin)
- Pancreatitis (rare)
- Liver enzyme elevations
Seek immediate medical attention if you experience abdominal pain, persistent fatigue, or difficulty breathing.
FAQs of Zomelis Met
Q1: How should I take Zomelis Met?
A: Take the tablet with meals to reduce gastrointestinal side effects. Follow your doctor’s dosage instructions strictly.
Q2: Can it cause low blood sugar?
A: It has a low risk of hypoglycemia when used alone, but the risk may increase when combined with insulin or sulfonylureas.
Q3: Is this medication suitable for weight management?
A: It is weight-neutral or may cause modest weight loss, making it suitable for overweight diabetic patients.
Q4: Can I take it if I have kidney problems?
A: Use is not recommended in patients with moderate to severe kidney impairment. Regular kidney monitoring is required.
Q5: What should I do if I miss a dose?
A: Take it as soon as you remember. If it's near the time of your next dose, skip the missed dose—do not double up.
Interactions of Zomelis Met
Zomelis Met may interact with:
- Diuretics, ACE inhibitors, and NSAIDs – may alter kidney function
- Beta-blockers – may mask symptoms of hypoglycemia
- Corticosteroids and thyroid hormones – may elevate blood glucose
- Alcohol – increases risk of lactic acidosis
- Always inform your healthcare provider about any medications or supplements you are taking.
| Manufacturer | : | Eris Lifesciences Ltd |
| Trade Name | : | Eucreas |
| Generic Search | : | Metformin + Vildagliptin |
| Strength | : | 500mg, 850mg, 1000mg. |
Latest Products
